ARROWHEAD PHARMACEUTICALS, INC. (ARWR) › Net IncomeARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Net IncomeAnnual figures by period end, from SEC filings.2003-09-30: -$95.2K2004-09-30: -$751.3K2005-09-30: -$6.73M2006-09-30: -$19.96M2007-09-30: -$30.71M2008-09-30: -$27.24M2009-09-30: -$19.31M2010-09-30: -$6.96M2011-09-30: -$3.49M2012-09-30: -$22.11M2013-09-30: -$31.70M2014-09-30: -$58.73M2015-09-30: -$91.94M2016-09-30: -$81.72M2017-09-30: -$34.38M2018-09-30: -$54.45M2019-09-30: $67.97M2020-09-30: -$84.55M2021-09-30: -$140.85M2022-09-30: -$176.49M2023-09-30: -$209.28M2024-09-30: -$609.69M2025-09-30: $30.11M$30.11M2003-09-30Net Income (USD)2025-09-30Period endedNet IncomeChange YoYSource filing2025-09-30$30.11M—2025-11-25From 2024-10-012024-09-30-$609.69M—2025-11-25From 2023-10-012023-09-30-$209.28M—2025-11-25From 2022-10-012022-09-30-$176.49M—2024-11-26From 2021-10-012021-09-30-$140.85M—2023-11-29From 2020-10-012020-09-30-$84.55M-224.4%2022-11-28From 2019-10-012019-09-30$67.97M—2021-11-22From 2018-10-012018-09-30-$54.45M—2020-11-23From 2017-10-012017-09-30-$34.38M—2019-11-25From 2016-10-012016-09-30-$81.72M—2018-12-11From 2015-10-012015-09-30-$91.94M—2017-12-12From 2014-10-012014-09-30-$58.73M—2016-12-14From 2013-10-012013-09-30-$31.70M—2015-12-14From 2012-10-012012-09-30-$22.11M—2014-11-25From 2011-10-012011-09-30-$3.49M—2013-12-18From 2010-10-012010-09-30-$6.96M—2013-12-18From 2009-10-012009-09-30-$19.31M—2013-12-18From 2008-10-012008-09-30-$27.24M—2013-12-18From 2007-10-012007-09-30-$30.71M—2013-12-18From 2006-10-012006-09-30-$19.96M—2013-12-18From 2005-10-012005-09-30-$6.73M—2013-12-18From 2004-10-012004-09-30-$751.3K—2013-12-18From 2003-10-012003-09-30-$95.2K—2013-12-18From 2002-10-01Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)